Vivos Therapeutics Inc Stock Ownership - Who owns Vivos Therapeutics?

Insider buying vs selling

Have Vivos Therapeutics Inc insiders been buying or selling?
Ronald Kirk HuntsmanChief Executive Officer2022-12-2320,000$0.50
Ronald Kirk HuntsmanChief Executive Officer2022-06-014,000$1.83
Ronald Kirk HuntsmanChief Executive Officer2022-05-318,000$2.03

1 of 1

VVOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VVOS insiders and whales buy or sell their stock.

VVOS Shareholders

What type of owners hold Vivos Therapeutics Inc stock?
Ronald Kirk Huntsman15.37%3,536,500$1.24MInsider
Gurdev Dave Singh13.99%3,219,705$1.13MInsider
Vanguard Group Inc3.18%731,842$256.14kInstitution
Geode Capital Management LLC0.88%201,941$70.68kInstitution
Bard Associates Inc0.88%201,704$70.60kInstitution
Credit Agricole S A0.26%59,103$20.69kInstitution
Perkins Capital Management Inc0.23%52,000$18.20kInstitution
Blackrock Inc0.20%47,107$16.49kInstitution
State Street Corp0.20%45,650$15.98kInstitution
Apexium Financial LP0.18%40,667$14.23kInstitution

1 of 3

VVOS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VVOS6.81%29.37%Net BuyingNet Buying
EAR47.76%52.24%Net BuyingNet Selling
NXL0.61%33.52%Net Buying
HSDT1.01%98.99%Net Buying

Vivos Therapeutics Stock Ownership FAQ

Who owns Vivos Therapeutics?

Vivos Therapeutics (NASDAQ: VVOS) is owned by 6.81% institutional shareholders, 29.37% Vivos Therapeutics insiders, and 63.83% retail investors. Ronald Kirk Huntsman is the largest individual Vivos Therapeutics shareholder, owning 3.54M shares representing 15.37% of the company. Ronald Kirk Huntsman's Vivos Therapeutics shares are currently valued at $1.24M.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.